-
Myanmar leader lands in Malaysia for migrant return talks
-
Chip industry activists call for South Korea to recognise cancer cases
-
Indian central bank hikes rates for first time since 2023
-
Famine-scarred southern Madagascar braces for El Nino
-
US military on Okinawa face curfew, alcohol ban after murder case
-
How the EU regulates lobbyists
-
Fierce lobbying in EU over 'forever chemicals'
-
I.Coast refuge offers lifelong care for youngsters scorned as 'sorcerers'
-
Dodgers beat Braves and Padres avoid sweep in MLB playoffs
-
Indian central bank hikes rates for first time in more than 3 years
-
Mourning, war and elections as Israel marks October 7
-
Hotel Blacklist Launches New Accommodation Industry Risk Assessment Tool
-
Messi says Argentina retirement is 'saddest day of my career'
-
Bangladesh nuclear plant draws hope -- and worry
-
Oil rises and stocks fall as Hormuz worries flare
-
US beat Canada 1-0 to wrap up four-win international break
-
Pacific presses world for help 'surviving' climate change at pre-COP summit
-
Turkey, Australia's joint COP31 leadership raises doubts
-
Verstappen revival to be put to the test in steamy Singapore
-
For Turkish NGOs, COP31 offers rare space for action
-
US woman who survived botched execution is conscious, speaking: lawyers
-
Sleep, appetite, gene-editing experts contend for Nobel chemistry prize
-
Climate champion Australia digging more coal
-
Nobel Peace Prize haunted by the 'spectre' of Trump
-
Emotion, tears as Messi retires from Argentina national team
-
Africa launches own credit agency in bid for cheaper borrowing
-
Dodgers push Braves to the brink of MLB playoff exit
-
US, China, EU: three paths to regulating AI
-
Crisis-stricken Haiti postpones elections
-
Australia's High Court rules against coal mine in landmark climate case
-
N. Korea's Kim pledges 'invariable support' in Putin birthday letter
-
Australia touts new funds for Pacific infrastructure at Fiji 'pre-COP'
-
OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
-
Eva Marie Saint, Oscar winner of Hollywood classics, dies at 102
-
Emotion, tears as Messi prepares for Argentina farewell
-
Australia probes app used in cheap smart glasses over privacy fears
-
Kane eyes Ronaldo record after matching England cap mark
-
England needed to 'move on' from World Cup pain, says Tuchel
-
Spain fight back to beat Croatia, Kane adds to record for England
-
O'Neill to stay at Celtic after period of "reflection"
-
Merino double helps Spain beat Croatia, reach Nations League quarters
-
Kane marks 125th England cap with Wembley Nations League double
-
US stocks hit fresh records as oil stabilizes on rising supplies
-
Quebec's incoming separatist leader wants to block Crown from swearing-in
-
As Messi bows out, Argentines say 'thank you'
-
Emmys gala will now stream its premier television awards
-
Ronaldo opens door for Portugal return, apologises for walkout
-
Paramount completes Warner Bros takeover, creating Skydance
-
'Nobody seems to care': Russian city shrugs off plague reports
-
Trump blames France unrest on Islam, migration
Preventative cholera vaccination resumes as global supply swells: WHO
The global cholera vaccine supply is finally high enough to allow regular vaccination campaigns to resume after a three-year halt, the World Health Organization and partners said Wednesday.
Dire vaccine shortages amid a surge in cholera cases forced a halt to preventative immunisation efforts in 2022, and a move to a one-dose strategy from the usual two in outbreak emergency responses.
But the WHO, along with the UN children's agency UNICEF and the Gavi vaccine alliance, announced Wednesday that the global supply had now increased "to a level sufficient to allow the resumption of life-saving preventative campaigns".
"Global vaccine shortages forced us into a cycle of reacting to cholera outbreaks instead of preventing them. We are now in a stronger position," said WHO chief Tedros Adhanom Ghebreyesus.
They groups said Mozambique was the first country to restart, with the country facing an ongoing cholera outbreak and reeling from floods that affected more than 700,000 people.
The flooding damaged water systems, further increasing the cholera risk.
A first allocation of 20 million doses is being deployed for preventive campaigns in three countries, with some 3.6 million doses delivered to Mozambique, 6.1 million going to the Democratic Republic of Congo, and the remaining 10.3 million doses intended for Bangladesh.
As the supply pipeline improves, one dose will remain the standard for outbreak responses, for now.
The doses are financed by Gavi, but procured and delivered to countries by UNICEF.
- 33 countries hit in 2025 -
Cholera is an acute intestinal infection that spreads through food and water contaminated with the bacterium vibrio cholerae, often from faeces.
It causes severe diarrhoea, vomiting and muscle cramps.
Cholera can kill within hours when not treated, though it can be treated with simple oral rehydration, and antibiotics for more severe cases.
UNICEF chief Catherine Russell said resuming preventive cholera vaccination would protect children, but "must go hand in hand with other efforts, including better access to safe water and basic sanitation".
More than 600,000 cases of cholera or acute watery diarrhoea and nearly 7,600 deaths were reported to the WHO from 33 countries last year, though the true numbers will be higher.
Global cholera cases rose every year from 2021 onwards then declined in 2025. However, the number of cholera deaths continued to increase.
Since October 2022, requests from 27 countries have been approved for emergency campaigns, with doses reaching almost 139 million people.
Annual global supply of oral cholera vaccine doubled from 35 million doses in 2022 to nearly 70 million doses in 2025.
"I thank EUBiologics, currently the only manufacturer producing cholera vaccines at the scale needed for mass vaccination campaigns, for its efforts, and urge others to enter this vital space," said Tedros.
R.Halabi--SF-PST